
Founder · CEO · Principal Investigator
Prof. Dr. Mike Barbeck
Founded BerlinAnalytix in 2018. His work connects biomaterial development with histological evidence of tissue response, inflammation and regeneration, drawing on research experience in academia and industry.
Background and qualifications
Studied human medicine at Goethe University Frankfurt and Johannes Gutenberg University Mainz, where he earned his doctorate in 2014. His research focuses on biomaterial development and tissue response.
Worked at the Institute of Pathology in Mainz, led an in-vivo research group at University Hospital Frankfurt, and served as Head of Research & Development at botiss biomaterials before founding BerlinAnalytix.
Leads a research group on the biology of biomaterials at University Medical Center Rostock. His histopathological and histomorphometric research examines macrophages, multinucleated giant cells and their relationship to tissue regeneration.
Biomaterial development · Tissue response · Histomorphometry










